-
Product Insights
Max Field, Colombia
Max upstream field is located in Casanare, Colombia. The upstream field is owned by GeoPark Colombia SAS (45%); Verano Energy Switzerland AG (55%). It is operated by GeoPark Colombia SAS. The project started its operations in 2012. Max Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves and capital and operating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-1 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Max-1 in Solid Tumor Drug Details: Max-1 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Solid Tumor Drug Details:MAX-4 is under development for the treatment of myelodysplastic syndrome, acute...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Gastric Cancer Drug Details:MAX-4 is under development for the treatment of myelodysplastic syndrome, acute...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-3 in Alopecia Areata
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Max-3 in Alopecia Areata Drug Details:Max-3 is under development for the treatment of alopecia areata and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Max-5 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Max-5 in Solid Tumor Drug Details: Max-5 is under development of the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:MAX-4 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Metastatic Colorectal Cancer Drug Details:MAX-4 is under development for the treatment of myelodysplastic syndrome,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAX-4 in Refractory Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MAX-4 in Refractory Acute Myeloid Leukemia Drug Details:MAX-4 is under development for the treatment of myelodysplastic...
-
Product Insights
Max Planck – Garching Max Planck Institute for Physics – Bavaria
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Planck - Garching Max Planck Institute for Physics - Bavaria report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Max Healthcare – Max Healthcare Super-Specialty Hospital Expansion – Punjab
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Healthcare - Max Healthcare Super-Specialty Hospital Expansion - Punjab report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Max Planck Soc – Halle Max Planck Institute Research Center – Saxony-Anhalt
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Planck Soc - Halle Max Planck Institute Research Center - Saxony-Anhalt report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
![]()
RE/MAX Holdings Inc – Company Profile
RE/MAX Holdings Inc (RE/MAX Holdings) is a real estate company that offers brokerage services. The company offers recruiting and retaining agents and sells franchises services, among others. RE/MAX Holdings franchisees operate under the brand names such as RE/MAX, Motto Mortgage, Wemlo etc. The company operates through two segments: real estate franchise services and brokerage. RE/MAX Holdings real estate franchise services segment comprises the operations of the company's owned and independent global franchising operations and its brokerages segment includes the brokerage...
Add to Basket -
Company Profile
![]()
Max Healthcare Institute Ltd – Company Profile
Max Healthcare Institute Ltd (Max Healthcare Institute) is a healthcare service provider that operates a chain of hospitals. The hospital offers urology, oncology, orthopedics, eye care, dermatology, lung transplant, nutrition, dental care, gastroenterology and rehabilitation services. It also offers services such as heart, cancer treatment, children care, diabetes, emergency and trauma, family medicine, hearing, home care, hospice, neurology, occupational medicine, orthopedics, palliative care, psychiatry, radiology, rehabilitation and therapy services and enabling patients to improve their health. It also offers education,...
Add to Basket -
Product Insights
Max Healthcare – Gurugram Hospital II – Haryana
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Healthcare - Gurugram Hospital II - Haryana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Oriental Max – Central Skies Serviced Apartments – Penang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Oriental Max - Central Skies Serviced Apartments - Penang report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
TriMet – MAX Red Line Rail Transit Extension – Oregon
Equip yourself with the essential tools needed to make informed and profitable decisions with our TriMet - MAX Red Line Rail Transit Extension - Oregon report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Quantum Immobilien – Max Brauer Mixed-Use Quarter – Hamburg
Equip yourself with the essential tools needed to make informed and profitable decisions with our Quantum Immobilien - Max Brauer Mixed-Use Quarter - Hamburg report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Costa Rican SSF – Max Peralta Hospital Development – Cartago
Equip yourself with the essential tools needed to make informed and profitable decisions with our Costa Rican SSF - Max Peralta Hospital Development - Cartago report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Oriental Max – Taman Ara Mutiara Mixed-Use Complex – Penang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Oriental Max - Taman Ara Mutiara Mixed-Use Complex - Penang report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.